Pharmafile Logo
Pharmafocus logo
Advanced Search

Scancell shares “highly encouraging” results from phase 1 COVID-19 vaccine trial

February 13, 2023
Research and Development

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief …

News

Sorrento Therapeutics’ subsidiary Scilex Holding Company acquires rights to acute migraine treatment

February 13, 2023
Sales and Marketing

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, has announced that it has acquired the rights to ELYXYBTM (celecoxib oral …

News

UK pharma packaging giant Origin celebrates its 60th anniversary

February 13, 2023
Business Services

13th FEBRUARY 2023, HULL, UK: Leading UK pharmaceutical packaging and solutions provider, Origin, is celebrating its 60th anniversary.   Origin …

News
Press release

CYDAR MEDICAL RAISES $11.5M (£9.3M) IN SERIES A FUNDING ROUND

February 13, 2023
Business Services

CAMBRIDGE, UNITED KINGDOM, 13 FEBRUARY 2023 – Cydar Medical (“Cydar” or “the Company”) a global, cloud-based surgical software company, announces …

News
Press release

AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime

February 10, 2023
Medical Communications

Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …

News

SynaptixBio secures FDA Rare Paediatric Disease designation to develop treatments for TUBB4a leukodystrophy

February 10, 2023
Research and Development

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …

News

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

February 10, 2023
Sales and Marketing

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug …

News

FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment

February 10, 2023
Medical Communications

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …

News

RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors

February 9, 2023
Business Services

LONDON, UK, 9 February 2023 — RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr …

Appointment

Stand Up To Cancer announces four teams dedicated to increasing diversity in clinical trials

February 9, 2023
Medical Communications

Stand Up To Cancer (SU2C) has announced four teams that will focus on increasing diversity in early phase cancer clinical …

News

FDA grants RMAT designation for Mesoblast’s chronic low back pain treatment

February 9, 2023
Medical Communications

Mesoblast Ltd, an Australian regenerative medicine company leading in allogeneic cellular medicines for inflammatory diseases, announced that its treatment for …

News

FDA approves Regeneron’s Eylea for the treatment of retinopathy of prematurity in infants

February 9, 2023
Research and Development

The FDA has approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of retinopathy of prematurity (ROP) in preterm infants. …

News

Garuda Therapeutics closes series B funding with $62m

February 9, 2023
Sales and Marketing

Cambridge-based Garuda Therapeutics announced it closed a $62m series B funding round to support its off-the-shelf, self-renewing blood stem cell …

News

The First Women in Leadership Network to Support Diversity, Equality and Inclusion across the Life Sciences Industry launched in Denmark

February 9, 2023
Business Services

9 February 2023, Denmark: Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior …

News
Press release

Redx Provides Progress Update on RXC007 Clinical Programme

February 9, 2023
Business Services

Alderley Park, UK, 9 February 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Sequana Medical announces 2022 Full Year Results and 2023 Outlook

February 9, 2023
Business Services

Ghent, Belgium – 09 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), a pioneer …

News
Press release

Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease

February 8, 2023
Business Services

READING, ENGLAND – Wednesday 8th February 2023. Sanofi announced today that healthcare specialists and patients living with Pompe disease will …

News
Press release

Scottish biotech aims to cure common cold

February 8, 2023
Medical Communications

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure …

News

Johnson & Johnson’s Ethicon undertakes first robot-assisted kidney stone removal

February 8, 2023
Research and Development

Johnson & Johnson (J&J) medtech company, Ethicon, has announced its first robotic-assisted kidney stone removal using its Monarch platform. The …

News

US Department of Justice asks Third Circuit to reinstate conspiracy charges again KVK

February 8, 2023
Manufacturing and Production

The US Department of Justice (DoJ) encouraged the Third Circuit to reinstate ‘conspiracy to defraud’ charges against Philadelphia-based generic drug …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025